Change - Announcement of Appointment::Appointment of Mr Mark Leong Kei Wei as Independent Non-Executive Director

Issuer & Securities

Issuer/ Manager
F J BENJAMIN HOLDINGS LTD
Securities
F J BENJAMIN HOLDINGS LTD - SG1D58018368 - F10
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
14-May-2026 22:14:31
Status
New
Announcement Sub Title
Appointment of Mr Mark Leong Kei Wei as Independent Non-Executive Director
Announcement Reference
SG260514OTHR5T11
Submitted By (Co./ Ind. Name)
Wendy Isabel Wong Pei Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr Mark Leong Kei Wei ("Mr Leong") as Independent Non-Executive Director, Chairman of the Nominating and Remuneration Committee as well as a member of the Audit Committee of F J Benjamin Holdings Ltd (the "Company", and together with its subsidiaries, the "Group").

This announcement has been reviewed by the Company's sponsor, ZICO Capital Pte. Ltd. (the "Sponsor").

This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Goh Mei Xian, ZICO Capital Pte. Ltd. at 77 Robinson Road, #06-03 Robinson 77, Singapore 068896, telephone (65) 6636 4201.

Additional Details

Date of appointment
15/05/2026
Name of person
Mark Leong Kei Wei
Age
49
Country of principal residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Nominating and Remuneration Committee has recommended the appointment of Mr Leong as an Independent Non-Executive Director of the Company. The Board of Directors of the Company (the "Board"), having reviewed the Nominating and Remuneration Committee's recommendation and assessed Mr Leong's experience, expertise, qualifications, independence and suitability, believes that Mr Leong's experience would be beneficial to the Group and his appointment would add diversity to the Board composition. Accordingly, the Board has approved the appointment of Mr Leong as an Independent Non-Executive Director of the Company.
Whether appointment is executive, and if so, the area of responsibility
The appointment is for a non-executive position.
Job title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Non-Executive Director, Chairman of the Nominating and Remuneration Committee as well as a member of the Audit Committee of the Company
Professional qualifications
1. Chartered Accountant of the Institute of Singapore Chartered Accountants (ISCA)
2. Fellow of the Association of Chartered Certified Accountants (ACCA)
3. Member of Singapore Institute of Directors (SID)
4. ASEAN Chartered Professional Accountant (ASEAN CPA)
Working experience and occupation(s) during the past 10 years
1. Executive Director, Osteopore Limited (December 2021 to present)
2. Executive Director, LifeBrandz Ltd (April 2023 to December 2023)
3. Director, Auspac Financial Advisory Pty Ltd (March 2021 to March 2023)
4. Chief Operating Officer, SBI Offshore Limited (November 2017 to August 2020)
5. Corporate Advisor, CNMC Pulai Mining Sdn Bhd (March 2017 to February 2018)
6. Executive Director, Chief Executive Officer and Chief Financial Officer, Pulai Mining Sdn Bhd (January 2016 to February 2017)
Shareholding interest in the listed issuer and its subsidiaries
No
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None
Conflict of interest (including any competing business)
None
Undertaking (in the format set out in Appendix 7.7 or Appendix 7H) under Mainboard Rule 720(1) or Catalist Rule 720(1) has been submitted to the listed issuer
Yes
Other Principal Commitments* Including Directorships#
* "Principal Commitments" has the same meaning as defined in the Code of Corporate Governance.
# These fields are not applicable for announcements of appointments pursuant to Mainboard Rule 704(9) or Catalist Rule 704(8).
Past (for the last 5 years)
- Top Mining Ltd
- Avalon Capital Pte. Ltd.
- Apeiron Agrocommodities Pte Ltd
- Catalano Seafood Ltd
- Cytomed Therapeutics (Malaysia) Sdn Bhd
- Auspac Management Services Pte Ltd
- Auspac Financial Advisory Pty Ltd
- Auspac Financial Services Pty Ltd
- LifeBrandz Ltd
- LifeBrandz Investment Management Pte Ltd
- The Green Bar Pte Ltd
- Cloud Eight Pte Ltd
- LB F&B Pte Ltd
- Superfood Kitchen Pte Ltd
- Takumi Holidays Pte Ltd
- Autagco Ltd
- Agewise Pte Ltd
- LCT Holdings Ltd
Present
- HS Optimus Holdings Limited
- 9R Limited
- Cytomed Therapeutics Limited
- Osteopore International Pte Ltd
- Landmark Reit Management Ltd (f.k.a. LMIRT Management Limited)
- mDR Limited
- Osteopore Limited
- Avalon Partners Pte Ltd
- Osteopore Australasia Pty Ltd
- Agewell Clinic Pty Ltd
- Ambertree Vic Mel (Lincoln) Pty Ltd
- PT Ambertree Development Jakarta
- Ambertree Pte Ltd
- K11 Energy Pte Ltd
- Saiko Consultancy Pte Ltd
- OsteoRx Pte Ltd
- PT Keleven Energi Makmur
- PT Keleven Energi Dana
- PT Saiko Consultancy Glorious
- PT Saiko Consultancy Grand
Information Required
Disclose the following matters concerning an appointment of director, chief executive officer, chief financial officer, chief operating officer, general manager or other officer of equivalent rank. If the answer to any question is "yes", full details must be given.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of:-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
Yes
If yes, please provide full details.
SBI Offshore Limited ("SBI")
Mr Leong was the Chief Operating Officer of SBI at the time SBI engaged KordaMentha Pte Ltd to conduct an independent review of SBI ("SBI Review"), as well as when SBI received a Notice of Compliance from the Singapore Exchange Regulation, which subsequently resulted in a special audit in relation to SBI ("SBI Special Audit"). In both the SBI Review and SBI Special Audit, Mr Leong facilitated the processes as part of the existing management team of SBI. The salient matters covered in both cases did not contain any direct involvement from Mr Leong and Mr Leong was not named in both reports relating to the SBI Review and the SBI Special Audit. For the avoidance of doubt, Mr Leong was not a subject of either the SBI Review nor of the SBI Special Audit.

mDR Limited ("mDR")
Mr Leong is serving as an independent director of mDR since his appointment in May 2017. In December 2021, mDR lodged a police report in relation to the suspected misappropriation of its inventories amounting to approximately S$2 million by 2 senior executives of mDR ("mDR Case"). For the avoidance of doubt, Mr Leong was not a subject matter of and had no involvement in the underlying mDR Case. In his capacity as an independent director of mDR and together with other board members of mDR, Mr Leong oversaw mDR's response in relation to the mDR Case. As at the date of this announcement, the relevant persons have been sentenced in relation to the underlying mDR Case.
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere,
in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of director only.
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If yes, please provide details of prior experience.
Mr Leong has the following experience serving currently as a director of issuers listed on the Singapore Exchange ("SGX"):
- 9R Limited - Independent Director;
- Landmark Reit Management Ltd (f.k.a. LMIRT Management Limited) - Independent Director;
- HS Optimus Holdings Limited - Independent Director; and
- mDR Limited - Lead Independent Director.

Mr Leong also previously served as a director of the following SGX-listed issuers:
- Lifebrandz Ltd - Executive Director;
- LCT Holdings Limited - Independent Director; and
- Advance SCT Limited - Independent Director.